INTEGRATED BIOPHARMA INC (INBP) Capital expenditures 2016–2025
INTEGRATED BIOPHARMA INC (INBP) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$191,000FY2025 · since FY2016: $109,000 → $191,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $191,000 | -65.5% |
| FY2024 | $553,000 | +376.7% |
| FY2023 | $116,000 | -76.1% |
| FY2022 | $486,000 | +64.7% |
| FY2021 | $295,000 | +37.9% |
| FY2020 | $214,000 | -48.3% |
| FY2019 | $414,000 | +67.6% |
| FY2018 | $247,000 | -24.5% |
| FY2017 | $327,000 | +200.0% |
| FY2016 | $109,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice